WATERLOO, Ontario--An agreement signed last week will give Allelix Biopharmaceuticals early access to Biomedical Photometrics' patented Genescope technology for reading genetic microarrays. Allelix will evaluate a preproduction version of the Genescope instrument to help accelerate its existing drug discovery programs, and will provide funding during this period. Both companies will share the rights to any inventions developed during the collaboration.